Key Performance
More- Earnings Score: N/A
- Momentum Score: 6
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures.
07/13/2026, 4:56 PM • GlobeNewswire
Rosen Law Firm is soliciting investors who purchased shares of Embecta Corp., Nano-X Imaging Ltd., and Lucid Group, Inc. during specified periods to join securities class action lawsuits. The lawsuits allege that these companies made false or misleading statements regarding financial guidance and business performance. Investors with losses exceeding $100,000 are encouraged to secure counsel before the August 17, 2026 lead plaintiff deadline.
07/13/2026, 4:48 PM • GlobeNewswire
A securities class action lawsuit has been filed against Nano-X Imaging (NNOX) alleging the company made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased cash burn, and restructuring risks. The lawsuit covers investors who purchased securities between March 31, 2025 and April 17, 2026. The deadline to seek lead plaintiff status is August 11, 2026. The action was triggered after Nano-X reported a $33.4 million net loss in Q4 2025, including a $17.5 million impairment charge related to restructuring at its Korean facility, causing the stock to fall 24.39%.
07/11/2026, 8:59 AM • GlobeNewswire
Rosen Law Firm is reminding investors in Nano-X Imaging Ltd. (NNOX) who purchased securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that company defendants made false statements about operational efficiency improvements and product demand, while concealing that manufacturing operations did not match actual demand, leading to increased operating expenses and cash burn.
07/10/2026, 2:51 PM • GlobeNewswire
A class action lawsuit has been filed against Nano-X Imaging Ltd. alleging that company executives made materially false and misleading statements regarding operational efficiency and product demand. The complaint claims Nano-X overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses and cash burn. Investors who purchased securities between March 31, 2025 and April 17, 2026 are eligible to join the case.
07/09/2026, 12:00 PM • GlobeNewswire
Rosen Law Firm is soliciting investors in Nano-X Imaging Ltd. (NNOX) who purchased securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that necessitated restructuring measures.
07/07/2026, 4:46 PM • GlobeNewswire
A securities class action lawsuit has been filed against Nano-X Imaging (NNOX) alleging the company made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased cash burn, and restructuring risks. The lawsuit covers purchases between March 31, 2025 and April 17, 2026. Investors have until August 11, 2026 to seek lead plaintiff status. The action follows Nano-X's April 2026 announcement of a $33.4 million quarterly loss including a $17.5 million asset impairment charge, which triggered a 24.39% stock price decline.
07/05/2026, 11:11 AM • GlobeNewswire
The Schall Law Firm is seeking investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about product demand and operational efficiency gains while suffering from poor customer alignment and increased cash burn.
07/03/2026, 9:44 AM • GlobeNewswire
Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.
07/01/2026, 8:49 PM • GlobeNewswire
Rosen Law Firm is pursuing securities class action lawsuits against ADMA Biologics, Nano-X Imaging, and DNOW Inc. on behalf of investors. The ADMA case alleges undisclosed related party transactions, channel stuffing, and inadequate internal controls during the August 2024 to March 2026 period, with an August 10, 2026 deadline for lead plaintiff claims.
07/01/2026, 8:39 PM • GlobeNewswire
Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Erasca Inc., Nano-X Imaging Ltd., Microsoft Corporation, and Black Rock Coffee Bar Inc. The lawsuits allege that defendants made false or misleading statements regarding their business operations, product performance, and financial prospects. Investors have until mid-August 2026 to file lead plaintiff motions.
07/01/2026, 1:49 PM • GlobeNewswire
Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits against companies including Nano-X Imaging, Peabody Energy, and First Solar. The lawsuits allege materially false statements and/or failure to disclose material facts regarding operational efficiency, mine ramp-up projections, and tariff policy management respectively. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by the announced deadlines in August 2026.
07/01/2026, 7:00 AM • GlobeNewswire
Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits. Nano-X Imaging faces allegations regarding false statements about operational efficiency and cash burn (deadline August 11, 2026). Peabody Energy is accused of misrepresenting its Centurion mine ramp-up and growth prospects (deadline August 24, 2026). First Solar faces claims about misstatements regarding its capacity to manage U.S. tariff policy impacts (deadline August 24, 2026).
06/29/2026, 7:00 AM • GlobeNewswire
Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures. The lead plaintiff deadline is August 11, 2026.
06/28/2026, 1:02 PM • GlobeNewswire
Kirby McInerney LLP has filed a securities fraud class action lawsuit against Nano-X Imaging Ltd. on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that Nano-X overstated operational efficiency gains and product demand while concealing poor alignment between production and actual demand, leading to increased operating expenses and cash burn. On April 20, 2026, Nano-X disclosed a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and announced its CFO's departure, causing the stock to decline 25% from $2.85 to $2.15 per share.
06/26/2026, 7:30 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 07/13/2026
Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.